Stay updated on Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial
Sign up to get notified when there's something new on the Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial page.

Latest updates to the Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check64 days agoChange DetectedThe webpage has been updated to reflect new information regarding a study on pancreatic cancer, including new drug names and collaborators, as well as revised dates for the study timeline. Significant details about the study's design and objectives have been removed.SummaryDifference26%
- Check72 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check115 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial page.